FDA On Legal Tightrope In Push To Restrict Drug Ads
The U.S. Food and Drug Administration helped unleash a flood of "direct to consumer" drug advertisements in the 1990s. Copious First Amendment protections for such commercial speech will be tough for the Trump administration to outmaneuver.
The Limits On Blue States' Push For Vaccine Policy Control
Democratic-run states are changing vaccine policies as HHS Secretary Robert F. Kennedy Jr. and other Trump health officials move to restrict vaccine access, creating a new policy patchwork. Those state efforts can only go so far, healthcare experts say.
Healthcare Deals This Week: Novartis, LB, Lila Sciences
A handful of sizable deals made headlines this past week, including a rare public offering from the pharmaceutical industry and a potential multibillion-dollar bet on the "molecular glue" space.
FDA On Legal Tightrope In Push To Restrict Drug Ads
The U.S. Food and Drug Administration helped unleash a flood of "direct to consumer" drug advertisements in the 1990s. Copious First Amendment protections for such commercial speech will be tough for the Trump administration to outmaneuver.
The Limits On Blue States' Push For Vaccine Policy Control
Democratic-run states are changing vaccine policies as HHS Secretary Robert F. Kennedy Jr. and other Trump health officials move to restrict vaccine access, creating a new policy patchwork. Those state efforts can only go so far, healthcare experts say.
Healthcare Deals This Week: Novartis, LB, Lila Sciences
A handful of sizable deals made headlines this past week, including a rare public offering from the pharmaceutical industry and a potential multibillion-dollar bet on the "molecular glue" space.
Expert Analysis
.jpg)
In light of the U.S. Department of Health and Human Services' Office of Civil Rights' continuing enforcement initi... (more story)
Several recent noncompete-related actions from the Federal Trade Commission — including its recent dismissal of ca... (more story)
Two recent rulings from Minnesota and Kentucky federal courts signal that past statements about claims-handling pr... (more story)
Deals & Corporate Governance More
The Centers for Medicare & Medicaid Services unreasonably evaluated whether a Wisconsin company was eligible to compete for a $48.5 million task order, the U.S. Government Accountability Office said, sustainin... (more story)
Yale New Haven Health Services Corp., Connecticut's largest hospital system, has reached a settlement in principle with bankrupt Prospect Medical Holdings Inc. that would resolve a $435 million contract disput... (more story)
Biopharmaceutical company BrainStorm Cell Therapeutics Inc. must face a proposed investor class alleging it misrepresented feedback from the U.S. Food and Drug Administration regarding clinical trials for an A... (more story)
Federal Trade Commission Chairman Andrew Ferguson vowed Tuesday to take unspecified "action" against tactics by merging companies to propose fixes only after antitrust enforcers bring a transaction challenge, ... (more story)
European life sciences venture capital firm EQT Life Sciences on Tuesday announced that its portfolio company VarmX, a Netherlands-based biotech, has entered into an exclusive option agreement to be bought by ... (more story)
An early investor in the Oura health and fitness tracker is fighting Ouraring Inc.'s attempt to send his $16 million dispute to arbitration in Finland, saying there is no underlying agreement to arbitrate and ... (more story)
Digital Health & Technology More
The Missouri attorney general can demand that a hospital turn over unredacted records on patients getting transgender care as part of a probe of a whistleblower complaint, a state appeals court held Tuesday.
A California federal judge has refused to disturb a jury verdict that found Meta Platforms Inc. liable for using an online tracking tool to unlawfully obtain sensitive health data that users entered into the F... (more story)
U.S. Sen. Ron Wyden, D-Ore., is calling on the Federal Trade Commission to open an investigation into Microsoft's "gross cybersecurity negligence" that has allegedly contributed to cyberattacks against critica... (more story)
A California judge has trimmed a proposed class action from shareholders of glucose monitor manufacturer DexCom Inc. who allege they were damaged by the company's misrepresentations regarding its ability to ke... (more story)
Epic Systems Corp. must face allegations it violated federal law by attempting to monopolize a segment of the electronic health records market to the exclusion of competitor Particle Health Inc. Here's what yo... (more story)
The U.S. Food and Drug Administration's internal artificial intelligence tool, new medical device guidance and a warning about wearable technology. Law360 Healthcare Authority explores these and other issues h... (more story)
Policy & Compliance More
A psychiatrist failed to convince the Second Circuit to reinstate his suit claiming a New York City-area hospital system forced him out because he raised patient safety concerns, with the appeals court saying ... (more story)
Whistleblowers filed a brief Wednesday in the Third Circuit in a closely watched False Claims Act appeal involving a $1.6 billion judgment against Johnson & Johnson unit Janssen as well as the constitutionalit... (more story)
The U.S. Food and Drug Administration on Tuesday sued manufacturers of flavored vapes in New Jersey federal court to seek an end to their sales, saying that they are falsely representing that their products ha... (more story)
The Third Circuit on Wednesday considered whether a Delaware woman with terminal cancer can challenge New Jersey's residency requirement for medical aid in dying, even though she has yet to be certified as hav... (more story)
A New York hospital system told a federal court Wednesday it will end a proposed class action alleging it failed to remove underperforming investment options from its retirement plan and keep an eye on adminis... (more story)
Susan Monarez, the former head of the Centers for Disease Control and Prevention, told federal lawmakers on Wednesday she was abruptly fired just weeks into her tenure for "holding the line on scientific integrity."